Omnipod® 5 FAQs:
SmartAdjust™ Technology

The Omnipod 5 Pod is enhanced with a control algorithm called SmartAdjust technology. Every 5 minutes, SmartAdjust technology receives CGM data and it takes this information and predicts where glucose will be 60 minutes into the future. It then increases, decreases, or pauses automated insulin using the user's customized Target Glucose settings.

Target Glucose is the only adjustable setting that directly impacts automated insulin delivery. The SmartBolus Calculator settings are adjustable and impact suggested bolus doses in Automated and Manual Modes.

The Omnipod 5 System uniquely adapts to the user's insulin needs with every Pod change.

No. The Omnipod 5 System does not have the ability to fine tune basal dosing in increments less than 0.05 units per hour.

No. Omnipod 5 is the only Automated Insulin Delivery System in the U.S. with a customized Target Glucose value of 110 mg/dL.

The SmartAdjust Technology is able to respond to high glucose levels by increasing insulin every 5 minutes to bring glucose down towards the Target Glucose. Omnipod 5 delivers a microbolus of insulin every 5 minutes to reduce blood glucose using the user's customized Target Glucose of 110-150mg/dL.

The Omnipod 5 System is cleared for use for people with type 1 diabetes aged 2 years and older using the same system and algorithm.

Automated insulin delivery in the first Pod is initiated based on user-selected basal rate profiles and then adapts over time by tracking insulin delivered by the system. With each new Pod activation, the system adapts insulin delivery based on physiological needs and total daily insulin (TDI) delivered. After 2-3 Pod changes, adaptation generally stabilizes and automated insulin delivery is based on this adaptation.

The SmartAdjust technology is a model predictive control algorithm that communicates with the Dexcom G6 CGM every 5 minutes and predicts where glucose will be in 60 minutes and increases, decreases or pauses insulin using a customized Target Glucose set by the user. The MiniMed 670G is a proportional-integral-derivative algorithm that takes CGM values from the Medtronic sensor and every 5 minutes adjusts insulin to a set target glucose of 120mg/dL. The Tandem Control:IQ system is also a model predictive control algorithm that communicates with the Dexcom G6 CGM and every 5 minutes predicts where glucose will be in 30 minutes and increases, decreases or pauses insulin to a target range rather than a customized glucose target.

You can adjust your Target Glucose which will impact your bolus calculations if you include a glucose value. The Target Glucose will not impact the basal insulin delivery during Automated Mode: Limited. You can also activate the Activity feature which may reduce basal delivery during Automated Mode: Limited. 

No, the algorithm adjusts with each new Pod activation based on physiological needs and total daily insulin (TDI) delivered.

Yes, it is still important to bolus before meals that contain carbohydrates. You should also bolus to correct high glucose levels. Follow the advice of your healthcare provider regarding bolus dosing and timing.